ATG4D and hepatocellular carcinoma: MiR-101 enhances cisplatin-induced apoptosis of HepG2 cells by inhibiting autophagy of targets such as member RAS oncogene family (RAB5A), STMN1, and autophagy-related 4D cysteine peptidase (AtG4D) in HCC [93].